Inoue H, Date Y, Kohashi K, Yoshitomi H, Tsuruta Y
Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyma University, Hiroshima, Japan.
Biol Pharm Bull. 1996 Feb;19(2):163-6. doi: 10.1248/bpb.19.163.
A method to measure total hydroxyproline (Hyp) and proline (Pro) in human serum and urine by HPLC was developed. Hyp and Pro in acid hydrolysates of serum and urine were derivatized with 4-(5,6-dimethoxy-2-phthalimidinyl)phenysulfonyl chloride after treatment with o-phthaladehyde and cleanup on Bond Elut C18 column. The derivatives of imino acids were separated on a reversed phase column by gradient elution with acetonitrile and phosphate buffer (1 mmol/l, pH 7) and detected by fluorescence measurement at 315 nm (excitation) and 385 nm (emission). Detection limits for both Hyp and Pro were 10 fmol per injection. The within-day and day-to-day relative standard deviations for Hyp and Pro in serum and urine were less than 3.19%. The recoveries of Hyp and Pro added to serum and urine were about 100%. The present method was applied to determine total Hyp and Pro in serum and urine from normal subjects and patients with chronic renal failure.
建立了一种通过高效液相色谱法测定人血清和尿液中总羟脯氨酸(Hyp)和脯氨酸(Pro)的方法。血清和尿液酸水解产物中的Hyp和Pro在用邻苯二甲醛处理后,用4-(5,6-二甲氧基-2-酞酰亚胺基)苯磺酰氯进行衍生化,并在Bond Elut C18柱上进行净化。亚氨基酸衍生物在反相柱上用乙腈和磷酸盐缓冲液(1 mmol/L,pH 7)进行梯度洗脱分离,并通过在315 nm(激发)和385 nm(发射)处的荧光测量进行检测。每次进样时Hyp和Pro的检测限均为10 fmol。血清和尿液中Hyp和Pro的日内和日间相对标准偏差均小于3.19%。添加到血清和尿液中的Hyp和Pro的回收率约为100%。本方法用于测定正常受试者和慢性肾衰竭患者血清和尿液中的总Hyp和Pro。